Skip to main content
Clinical Trials/CTRI/2025/05/086193
CTRI/2025/05/086193Not yet recruitingPhase 4

A comparative clinical study to evaluate the effects of Kulathadi Kwatha and Pauskaradi Churna in the management of Shwasa Roga w.s.r. to Chronic Obstructive Pulmonary Disease(COPD).

Prof Dr Vijay Chaudhary1 site in 1 country30 target enrollmentStarted: June 20, 2025Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To assess the efficacy of Kulathadi Kwatha and Pauskaradi Churna in management of Shwasa Roga

Study Overview

Brief Summary

At the end of clinical trial the results wills be statistically analysed and will be presented in the form of thesis.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
50.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients willing to participate in trial for 4weeks.
  • Patients who fulfill the diagnostic criteria.
  • Patients between the age group of 50 to 70 years.

Exclusion Criteria

  • Patients not willing to participate in trial.
  • Patients who does notfulfill the diagnostic criteria.
  • Patients between the age group below 50 and above 70 years.

Outcomes

Primary Outcomes

To assess the efficacy of Kulathadi Kwatha and Pauskaradi Churna in management of Shwasa Roga

Time Frame: 30 days

Secondary Outcomes

  • To Assess the clinical safety and untoward effects of Kulathadi Kwatha and Pauskaradi Churna in management of Shwasa Roga(30 days)

Investigators

Sponsor
Prof Dr Vijay Chaudhary
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials